CervoMed CRVO
NASDAQ CRVO
$3.02 +0.09 (+3.07%)
At close: Oct 2, 2026 · 4:00 PM EDT

CervoMed (CRVO) Income from Discontinued Operations (2013)

Updated

CervoMed's Income from Discontinued Operations was $656,541 in Q4 2013, up 539.1% from the prior quarter.

Analysis

CervoMed (CRVO) Income from Discontinued Operations (2013) Analysis & Trends

For FY2013, Income from Discontinued Operations at CervoMed came in at $503,207.

  • Per Business Quant data, CRVO's Income from Discontinued Operations in the three quarters before Q4 2013 was $102,734 (Q3 2013), -$129,157 (Q2 2013) and -$126,911 (Q1 2013).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Discontinued) (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 8.00 Mn
10 CervoMed 30.94 Mn 30.94 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2013 656,541.00
Sep 30, 2013 102,734.00
Jun 30, 2013 -129,157.00
Mar 31, 2013 -126,911.00
API Access

CervoMed Income from Discontinued Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-from-discontinued-operations&ticker=CRVO&period=max&api_key=YOUR_API_KEY